News
-
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Bespak Confirms Completion of Inhaled and Nasal Drug Delivery Business Separation From Recipharm to Focus on the Transition to Low GWP pMDIs
Bespak completes spin-out to form leading global CDMO focused on drug-device combination products and announces investments at Holmes Chapel site -
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: CTS EVENTIM enters put option agreement to acquire Vivendi’s festival and international ticketing activities
CTS EVENTIM AG & Co. KGaA enters put option agreement to acquire Vivendi’s festival and international ticketing activities generating €137 million in revenues in 2023 -